CareLit · DOI-Nachweis · Pneumologie
Molecular testing, frequency of molecular alterations and targeted 1st-line treatment of patients with non-small cell lung carcinoma in Germany. Results from the prospective German Registry CRISP (AIO-TRK-0315)
DOI 10.1055/s-0039-1678074
Bibliografische Angaben
Nachweis in CareLit
Autor:innenF Griesinger, WEE Eberhardt, A Nusch, M Reiser, M Zahn, N Marschner, M Jänicke, A Fleitz, L Spring, J Sahlmann, A Karatas, A Hipper, W Weichert, A Rittmeyer, P Christopoulos, C Waller, M Sebastian, M Thomas
ZeitschriftPneumologie
AusgabeS 01 S 01/2019
Jahrgang / SeitenJg. 73
Kernaussage aus der Literatur
Abstract-Vorschau
Molecular testing, frequency of molecular alterations and targeted 1st-line treatment of patients with non-small cell lung carcinoma in Germany. Results from the prospective German Registry CRISP (AIO-TRK-0315)
Zitieren
Zitierempfehlung
F Griesinger, WEE Eberhardt, A Nusch, M Reiser, M Zahn, N Marschner, M Jänicke, A Fleitz, L Spring, J Sahlmann, A Karatas, A Hipper, W Weichert, A Rittmeyer, P Christopoulos, C Waller, M Sebastian, M Thomas (2019) Molecular testing, frequency of molecular alterations and targeted 1st-line treatment of patients with non-small cell lung carcinoma in Germany. Results from the prospective German Registry CRISP (AIO-TRK-0315). Pneumologie, 73 (S 01 S 01). https://doi.org/10.1055/s-0039-1678074
Mit CareLit weiterarbeiten